12:00 AM
 | 
Oct 06, 2008
 |  BC Week In Review  |  Company News  |  Deals

Advanced Life Sciences Inc., Wyeth deal

Advanced Life Sciences granted Wyeth exclusive rights to develop and commercialize cethromycin to treat mild to moderate community-acquired pneumonia (CAP) in 24 Asia-Pacific countries, excluding Japan. Wyeth purchased about 1.9 million...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >